Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Illumina Urges Stockholders To Turn Down Roche's Offer & Vote For Its Nominees

RELATED NEWS
Trade ILMN now with 

Illumina, Inc. (ILMN: Quote) said it is sending a letter from its Board of Directors highlighting supportive reports issued by two of the nation's leading proxy advisor firms. The company's Board recommends that stockholders reject Roche's (RHHBY.PK) offer and vote for the election of its highly qualified nominees at its 2012 Annual Meeting of Stockholders by completing the WHITE proxy card on April 9, 2012.

Illumina also urged its shareholders to vote the WHITE PROXY CARD to re-elect to the Board four highly qualified and experienced directors, Blaine Bowman; Karin Eastham; Jay Flatley, President and CEO; and William Rastetter, Chairman.

Click here to receive FREE breaking news email alerts for Illumina Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.